1. |
|
|
2. |
|
|
3. |
- Aagaard, Marianne, 1985-
(author)
-
Naivt tro att EU kan stoppa bedrägerierna
- 2024
-
Other publication (pop. science, debate, etc.)abstract
- Vi kan inte förlita oss på att EU löser våra problem, utan måste själva skapa regler som gynnar trygga betalningssätt.
|
|
4. |
|
|
5. |
|
|
6. |
- Aage, Hans
(author)
-
46. Trends in economic transition
- 2002. - 1
-
In: The Baltic Sea Region. - Uppsala : Baltic University Press. - 9197357987 ; , s. 591-600
-
Book chapter (pop. science, debate, etc.)
|
|
7. |
- Aage, Hans
(author)
-
50. EU enlargement
- 2001. - 1
-
In: The Baltic Sea Region. - Uppsala : Baltic University Press. - 9197357987 ; , s. 630-638
-
Book chapter (pop. science, debate, etc.)
|
|
8. |
- Aage, Hans
(author)
-
51. The environment
- 2002. - 1
-
In: The Baltic Sea Region. - Uppsala : Baltic University Press. - 9197357987 ; , s. 639-650
-
Book chapter (pop. science, debate, etc.)
|
|
9. |
- Aahlin, Kristofer, et al.
(author)
-
Preparation of 1-(4-(5-amino-6-(oxazolo[4,5-c]pyridin-2-yl)pyrazin-2-yl)benzoyl)piperazine derivatives as glycogen synthase kinase 3 inhibitors.
- 2011
-
Patent (pop. science, debate, etc.)abstract
- Title compds. I [R1 = H or Me], and their pharmaceutically acceptable salts, are prepd. and disclosed as glycogen synthase kinase 3 (GSK3) inhibitors. Thus, e.g., II was prepd. by cyclization of 3-amino-N-(4-hydroxypyridin-3-yl)pyrazine-2-carboxamide (prepn. given) to get intermediate 3-(oxazolo[4,5-c]pyridin-2-yl)pyrazin-2-amine, which underwent bromination followed by Suzuki reaction with (4-methylpiperazin-1-yl)(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone. Compds. of the invention were tested for their selective inhibitory activity of GSK3β, e.g., II exhibited Ki value of 2.3 nM. The invention compds. are useful for the treatment of cognitive disorders, diabetes, cancer, etc. [on SciFinder(R)]
|
|
10. |
|
|